IRIS
GNETTI, Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.931
EU - Europa 1.648
AS - Asia 556
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.919
CN - Cina 444
IE - Irlanda 427
SE - Svezia 396
IT - Italia 387
DE - Germania 86
AT - Austria 73
FR - Francia 65
FI - Finlandia 58
TR - Turchia 47
UA - Ucraina 39
GB - Regno Unito 36
BE - Belgio 34
SG - Singapore 30
IN - India 18
CZ - Repubblica Ceca 14
CA - Canada 10
RU - Federazione Russa 9
NL - Olanda 6
CH - Svizzera 4
JP - Giappone 4
AL - Albania 3
ES - Italia 3
HK - Hong Kong 3
VN - Vietnam 3
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
CI - Costa d'Avorio 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
HR - Croazia 1
IR - Iran 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 4.143
Salva come PNG Salva come JPEG
Città #
Chandler 552
Dublin 423
Ann Arbor 160
Ashburn 130
New York 90
Beijing 87
Dearborn 87
Parma 85
Vienna 73
Shanghai 72
Nanjing 66
Princeton 65
Boardman 43
Izmir 42
Rio Saliceto 40
Jacksonville 36
Wilmington 35
Bremen 32
Jinan 32
Brussels 28
Des Moines 21
Los Angeles 20
Helsinki 19
Hebei 18
Kunming 18
Bologna 17
San Mateo 17
Seattle 16
Fremont 15
Shenyang 15
Changsha 14
Hefei 14
Tianjin 14
West Jordan 14
Guangzhou 13
Jiaxing 11
Redwood City 11
Houston 10
Norwalk 10
Woodbridge 10
Milan 9
Nanchang 9
Fairfield 7
Brno 6
Louvain-la-Neuve 6
Modena 6
Pune 6
Reggio Emilia 6
Toronto 6
Bolzano 5
Falls Church 5
London 5
Rome 5
Borås 4
Busseto 4
Catania 4
Chengdu 4
Fuzhou 4
Genova 4
Haikou 4
Simi Valley 4
Zhengzhou 4
Auburn Hills 3
Chicago 3
Edinburgh 3
Fislisbach 3
Grafing 3
Kocaeli 3
Lanzhou 3
Massarosa 3
Pavia 3
Taiyuan 3
Tirana 3
Tulsa 3
Valmadrera 3
Almaty 2
Andover 2
Bari 2
Budapest 2
Candiac 2
Centro 2
Dong Ket 2
Forlì 2
Hangzhou 2
Hong Kong 2
Istanbul 2
Leawood 2
Maranello 2
Minerbio 2
Mondavio 2
Monmouth Junction 2
Nürnberg 2
Palermo 2
Paris 2
Portland 2
Reggio Nell'emilia 2
Rockville 2
Salsomaggiore Terme 2
Scottsdale 2
Sondrio 2
Totale 2.681
Salva come PNG Salva come JPEG
Nome #
Leiomioma metastatizzante benigno gigante 124
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 123
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 111
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 110
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 97
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 95
Widespread Nivolumab-induced Enteropathy in a Long Responder Non–Small-cell Lung Cancer Patient 93
Early fetal akinesia sequence: A case report with unusual autoptic features 89
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 86
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 85
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 84
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 79
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 73
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 73
Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features and emphasis in the HPV status 72
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 71
Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy 71
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 70
Computed tomography - histology correlations of unusual lung tumors 68
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 68
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC 66
Pili canaliculi: a familial study 66
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 66
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 65
Vulvar acantholytic squamous carcinoma: a case report with immunohistochemical and molecular study. 65
Multiple primary malignancies involving lung cancer: a single-center experience 64
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 63
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 62
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 61
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 60
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib 60
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 60
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 59
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 59
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 58
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 58
Oncocytic mucoepidermoid carcinoma of a submandibular gland: a case report and review of the literature. 57
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 57
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 56
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 56
Tubercolosi pleurica multi-resistente in gravidanza: Challenge diagnostico e terapeutico 54
GIANT PRIMARY DEDIFFERENTIATED LIPOSARCOMA OF THE ANTERIOR MEDIASTINUM: AN EXTREMELY RARE OCCURRENCE 52
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs) 52
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 52
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 52
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 51
Spread through air spaces in lung adenocarcinoma: Is radiology reliable yet? 48
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial 48
KRAS: A Druggable Target in Colon Cancer Patients 48
Lung Manifestation of IgG4-related Disease. A multifaceted disorder. Presentation of two cases and short review of literature 46
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 45
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 45
SOLITARY FIBROUS TUMOR OF THE PLEURA ASSOCIATED WITH SEVERE HYPOGLICEMIA: THE DOEGE-POTTER SYNDROME 44
Very late recurrence of an apparently benign pheochromocytoma 41
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy 41
A case of Solitary fibrous pleura tumor associated with severe hypoglycemia: the Doege-Potter 's Syndrome 40
Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib 40
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 39
Malignant deciduoid pleural mesothelioma: A case report 38
Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women 36
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study 34
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 33
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 32
Activity of lenvatinib plus everolimus combination in a heavily pretreated patient with papillary renal cell carcinoma: a case report 32
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 29
Retroperitoneal cystoadenocarcinoma: A case report with a literature review 28
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights 26
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 25
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 24
Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review 23
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 22
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 21
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 20
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 18
Cryptogenic Fibrosing Pleuritis 18
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 12
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 11
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 8
Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC 5
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 5
Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC 5
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 5
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 5
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 3
Totale 4.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.161
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201966 0 0 0 0 0 0 0 0 0 0 61 5
2019/2020595 106 102 14 12 48 87 58 27 36 67 18 20
2020/2021388 12 20 16 57 52 37 19 24 60 19 49 23
2021/2022403 22 13 5 18 8 13 76 27 20 31 25 145
2022/20231.828 168 240 106 151 151 222 24 125 522 14 76 29
2023/2024655 32 68 14 31 48 176 82 51 50 74 29 0
Totale 4.316